Relevant bibliographies by topics / Virus diseases – Chemotherapy

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Virus diseases – Chemotherapy'

Author: Grafiati
Published: 25 July 2024
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Virus diseases – Chemotherapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Virus diseases – Chemotherapy"

1

Talib Al-Nafakh, Rana. "Epstein–Barr Virus and Rheumatoid Arthritis in Cancer Patients Undergoing Chemotherapy in Al-Najaf Province, Iraq." Journal of Communicable Diseases 55, no. 04 (2024): 119–25. http://dx.doi.org/10.24321/0019.5138.202364.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rollinson, E. A. "Prospects for Antiviral Chemotherapy in Veterinary Medicine: 1. Feline Virus Diseases." Antiviral Chemistry and Chemotherapy 3, no. 5 (1992): 249–62. http://dx.doi.org/10.1177/095632029200300501.

Full text
Abstract:
This paper, which is published in two parts, reviews the literature pertaining to antiviral chemotherapy of viruses of veterinary importance. While early reports in the 1970s referred to the chemotherapy of a number of different RNA and DNA viruses, there was considerable focus in the 1980s, initially on herpesviruses and latterly on retroviruses, particularly in cats. Details are given of the successful treatments of FeLV and FIV, which have been used as animal models for HIV therapy. The high costs of developing and registering a new chemical entity, especially for food species, in which ext
APA, Harvard, Vancouver, ISO, and other styles
3

Snoeck, R., G. Andrei, and E. De Clercq. "Chemotherapy of varicella zoster virus infections." International Journal of Antimicrobial Agents 4, no. 3 (1994): 211–26. http://dx.doi.org/10.1016/0924-8579(94)90011-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Polsky, Bruce. "Antiviral Chemotherapy for Infection with Human Immunodeficiency Virus." Clinical Infectious Diseases 11, Supplement_7 (1989): S1648—S1663. http://dx.doi.org/10.1093/clinids/11.supplement_7.s1648.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Han, Seung Beom, Hye Jo Shin, Eui Soo Lee, et al. "SEROLOGICAL CHANGES AGAINST HEPATITIS B SURFACE ANTIGEN IN CHILDREN AND ADOLESCENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIA." Mediterranean Journal of Hematology and Infectious Diseases 11, no. 1 (2019): e2019052. http://dx.doi.org/10.4084/mjhid.2019.052.

Full text
Abstract:
Background: Vaccination for hepatitis B virus (HBV) after chemotherapy among pediatric patients with acute leukemia is still a debated issue. We investigated HBV immunity before and after chemotherapy and assessed immune response to re-vaccination after chemotherapy.
 Methods: We retrospectively analyzed data of children and adolescents aged <19 years requested for vaccination after chemotherapy for acute leukemia to evaluate hepatitis B surface antibody (HBsAb) status before and after chemotherapy and to identify factors related to HBsAb positivity after chemotherapy.
 Results: O
APA, Harvard, Vancouver, ISO, and other styles
6

Rice, W. G., and J. A. Turpin. "Virus-encoded Zinc Fingers as Targets for Antiviral Chemotherapy." Reviews in Medical Virology 6, no. 4 (1996): 187–99. http://dx.doi.org/10.1002/(sici)1099-1654(199612)6:4<187::aid-rmv176>3.0.co;2-f.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wainberg, Mark A., Andre Dascal, and Jack Mendelson. "Anti-Retroviral Strategies for AIDS and Related Diseases." Canadian Journal of Infectious Diseases 2, no. 3 (1991): 121–28. http://dx.doi.org/10.1155/1991/487657.

Full text
Abstract:
The replication cycle of human immunodeficiency virus type 1 (HIV-1) and other retroviruses consists of four stages: attachment of the virus to specific receptors on the cell surface; uncoating of the viral nucleic acid and conversion to DNA; production of viral RNA and proteins; and assembly and liberation of progeny virus from the cell. Each of these steps represents a potential target for antiviral chemotherapy. Combinations of drugs which act against different steps in the viral replication cycle might be expected to have synergistic potential. Zidovudine (AZT) is the most widely used drug
APA, Harvard, Vancouver, ISO, and other styles
8

FIELD, HUGH J. "The impact of drug resistance upon virus chemotherapy." Journal of Antimicrobial Chemotherapy 24, no. 1 (1989): 4–7. http://dx.doi.org/10.1093/jac/24.1.4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Benke, Ashwini Prashant, Ram Krishna, Kiran Khandagale, et al. "Efficient Elimination of Viruses from Garlic Using a Combination of Shoot Meristem Culture, Thermotherapy, and Chemical Treatment." Pathogens 12, no. 1 (2023): 129. http://dx.doi.org/10.3390/pathogens12010129.

Full text
Abstract:
Garlic (Allium sativum L.) is a clonally propagated bulbous crop and can be infected by several viruses under field conditions. A virus complex reduces garlic yield and deteriorates the quality of the produce. In the present study, we aimed to eliminate Onion yellow dwarf virus (OYDV), Garlic common latent virus (GCLV), Shallot latent virus (SLV), and Allexiviruses from the infected crop using combination of meristem culture, thermotherapy, and chemotherapy. In this study, seven different treatments, namely shoot meristem culture, thermotherapy direct culture, chemotherapy direct culture, chem
APA, Harvard, Vancouver, ISO, and other styles
10

Dorobantu, Cristina M., Christian Harak, Rahel Klein та ін. "Tyrphostin AG1478 Inhibits Encephalomyocarditis Virus and Hepatitis C Virus by Targeting Phosphatidylinositol 4-Kinase IIIα". Antimicrobial Agents and Chemotherapy 60, № 10 (2016): 6402–6. http://dx.doi.org/10.1128/aac.01331-16.

Full text
Abstract:
ABSTRACTEncephalomyocarditis virus (EMCV), like hepatitis C virus (HCV), requires phosphatidylinositol 4-kinase IIIα (PI4KA) for genome replication. Here, we demonstrate that tyrphostin AG1478, a known epidermal growth factor receptor (EGFR) inhibitor, also inhibits PI4KA activity, bothin vitroand in cells. AG1478 impaired replication of EMCV and HCV but not that of an EMCV mutant previously shown to escape PI4KA inhibition. This work uncovers novel cellular and antiviral properties of AG1478, a compound previously regarded only as a cancer chemotherapy agent.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Virus diseases – Chemotherapy"

1

Abdukalykova, Saule. "Cellular and humoral immune responses in birds fed different levels of Arginine and vitamin E." Thesis, McGill University, 2007. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=100753.

Full text
Abstract:
The effects of vitamin E (VE) and Arginine (ARG) on humoral and cellular immunity in chickens were investigated in two experiments. The humoral immunity was measured by antibody responses to sheep red blood cells (SRBC) and maternal antibody titers to the infectious bursal disease virus (IBDV), while the cellular immunity was studied using the cutaneous basophil hypersensitivity test to phytogemagglutinin (PHA) and by counting subpopulations of T-lymphocytes. We used two levels of ARG: normal (NARG, 1.2% in feed) and high ARG (HARG, additional 0.3% in drinking water or 1% in feed in experiment
APA, Harvard, Vancouver, ISO, and other styles
2

Peltier, Cécile. "Prévention de la transmission du VIH-1 par le lait maternel au Rwanda et dépistage précoce des enfants infectés." Doctoral thesis, Universite Libre de Bruxelles, 2012. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/209572.

Full text
Abstract:
Ce travail est réparti en deux parties différentes issues de deux études différentes.<p>La première partie décrit l’étude AMATA conçue en 2005 au Rwanda, étude prospective basée sur le suivi d’une cohorte répartie en deux groupes d’intervention postnatale. Cette étude avait pour objectif de tester l’hypothèse que l’allaitement maternel (AM) sous trithérapie antirétrovirale maternelle (HAART) pouvait être une prévention aussi efficace que le lait artificiel (LA) afin de réduire drastiquement la transmission du virus VIH de la mère à l’enfant avec une moindre mortalité infantile. Cette intervent
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Virus diseases – Chemotherapy"

1

Challand, Richard. Antiviral chemotherapy. Spektrum, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Edouard, Kurstak, ed. New vaccines and chemotherapy. Plenum Medical Book Co., 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hans-Georg, Kräusslich, Oroszlan Stephen, Wimmer Eckard, and Cold Spring Harbor Laboratory, eds. Viral proteinases as targets for chemotherapy. Cold Spring Harbor Laboratory Press, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

J, Galasso George, Whitley Richard J, and Merigan Thmomas C, eds. Antiviral agents and viral diseases of man. 3rd ed. Raven Press, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

1940-, Mills John, Corey Lawrence, and Triennial Conference on Antiviral Chemotherapy (3rd : 1991 : San Francisco, Calif.), eds. Antiviral chemotherapy: New directions for clinical applications and research. PTR Prentice Hall, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

E, Blair, ed. Antiviral therapy. BIOS Scientific Publishers, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

1948-, Sacks Stephen L., ed. Clinical management of herpes viruses. IOS Press, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

International Symposiumon Pharmacological and Clinical Approaches to Herpes Viruses and Virus chemotherapy (1984 Oiso, Japan). Herpes viruses and virus chemotherapy: Pharmacological and clinical approaches : proceedings of the International Symposium on Pharmacological and Clinical Approaches to Herpes Viruses and Virus Chemotherapy, Oiso, Japan, 10-13 September 1984. Edited by Kono R. 1915-1985 and Nakajima A. Excerpta Medica, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

J, Dimmock N., Griffiths P. D, and Madeley C. R, eds. Control of virus diseases: Forty-fifth Symposium of the Society for General Microbiology, held at the University of Warwick, April 1990. Cambridge University Press, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Reisaku, Kōno, and Nakajima Akira 1927-, eds. Herpes viruses and virus chemotherapy: Pharmocological and clinical approaches : proceedings of the International Symposium on Pharmacological and Clinical Approaches to Herpes Viruses and Virus Chemotherapy, Oiso, Japan, 10-13 September 1984. Excerpta Medica, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Virus diseases – Chemotherapy"

1

Griffin, B. E. "Epstein-Barr Virus and Malignant Diseases." In Progress in Anti-Cancer Chemotherapy. Springer Paris, 1999. http://dx.doi.org/10.1007/978-2-8178-0918-2_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Faccioli, G. "Control of Potato Viruses using Meristem and Stem-cutting Cultures, Thermotherapy and Chemotherapy." In Virus and Virus-like Diseases of Potatoes and Production of Seed-Potatoes. Springer Netherlands, 2001. http://dx.doi.org/10.1007/978-94-007-0842-6_28.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Piette, J., C. Sappey, B. Piret, and S. Legrand-Poels. "Redox Regulation of the Human Immunodeficiency Virus Type 1 (HIV-1)." In DNA and RNA Cleavers and Chemotherapy of Cancer and Viral Diseases. Springer Netherlands, 1996. http://dx.doi.org/10.1007/978-94-009-0251-0_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Armand, J. P., E. Cvitrovic, and M. Bachouchi. "Chemotherapy in Undifferentiated Type Nasopharyngeal Carcinoma (UCNT)." In Epstein-Barr Virus and Human Disease • 1990. Humana Press, 1991. http://dx.doi.org/10.1007/978-1-4612-0405-3_59.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Chen, K. Y., C. K. Law, K. H. Chi, et al. "Neoadjuvant Chemotherapy Plus Radiotherapy Versus Radiotherapy Alone in Nasopharyngeal Cancer." In Epstein-Barr Virus and Human Disease • 1990. Humana Press, 1991. http://dx.doi.org/10.1007/978-1-4612-0405-3_60.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Domenge, C., J. L. Marin, J. P. Droz, F. Eschwege, G. Schwaab, and J. M. Richard. "Post-Radiotherapy Adjuvant Chemotherapy of Regionally Advanced UNPC: Increase in Disease Free Survival." In Epstein-Barr Virus and Human Disease. Humana Press, 1987. http://dx.doi.org/10.1007/978-1-4612-4590-2_105.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Corey, L. "Current Status of Antiviral Chemotherapy for Genital Herpes Simplex Virus Infection: Its Impact on Disease Control." In Perspectives in Antiinfective Therapy. Vieweg+Teubner Verlag, 1989. http://dx.doi.org/10.1007/978-3-322-86064-4_29.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Corey, L. "Current Status of Antiviral Chemotherapy for Genital Herpes Simplex Virus Infection: Its Impact on Disease Control." In Perspectives in Antiinfective Therapy. Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-46666-3_30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ayodele, Olubukola, and Lillian L. Siu. "New Drugs for Recurrent or Metastatic Nasopharyngeal Cancer." In Critical Issues in Head and Neck Oncology. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-63234-2_23.

Full text
Abstract:
AbstractChemotherapy has been the backbone for the treatment of recurrent or metastatic nasopharyngeal carcinoma (RMNPC), which remains an incurable disease. Currently the most active area of therapeutic investigations in RMNPC is in immunotherapy, especially after the results of five anti-programmed death-1 (anti-PD-1) antibodies, i.e. pembrolizumab, nivolumab, camrelizumab, toripalimab and tislelizumab, have demonstrated monotherapy objective response rates of 21%–43%. Combinations using anti-PD1/L1 antibodies as backbone to evaluate their additivity or synergy with cytotoxic chemotherapy, m
APA, Harvard, Vancouver, ISO, and other styles
10

Srayaldeen, Salman Wahib, and Mohamed Ahmed Mohamed Elkhalifa. "Hepatocellular Carcinoma (HCC) in the UAE." In Cancer Care in the United Arab Emirates. Springer Nature Singapore, 2024. http://dx.doi.org/10.1007/978-981-99-6794-0_30.

Full text
Abstract:
AbstractThe incidence of HCC in the UAE has been stable, with around 60–100 cases per year in the UAE between 2013 and 2021, with a potential future increase in incidence with rising rates of obesity, diabetes, and excessive alcohol consumption, as well as hepatitis B virus, hepatitis C virus, and nonalcoholic steatohepatitis (NASH).The age-specific incidence of HCC peaks between 80 and 90 years old, but new cases can be detected as early as 40 due to alcoholic liver disease. The prevalence of hepatitis C is low (0.1%) due to the availability of universal hepatitis B vaccination at birth. Howe
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Virus diseases – Chemotherapy"

1

Rabbani, Naila, Paul John Thornalley, Maryam Al-Motawa, and Mingzhan Xue. "Vulnerabilities of the SARS-Cov-2 Virus to Proteotoxicity – Opportunity for Repurposed Chemotherapy of COVID-19 Infection." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0291.

Full text
Abstract:
The global pandemic of COVID-19 disease caused by infection with the SARS-CoV-2 Coronavirus, has produced an urgent requirement and search for improved treatments whilst effective vaccines are developed. A strategy for improved drug therapy is to increase levels of endogenous reactive metabolites for selective toxicity to SARS-CoV-2 by preferential damage to the viral proteome. Key reactive metabolites producing major quantitative damage to the proteome in physiological systems are: Reactive oxygen species (ROS) and the reactive glycating agent methylglyoxal (MG); cysteine residues and arginin
APA, Harvard, Vancouver, ISO, and other styles
2

Goi, Mariana Copetti, Ana Paula Santana de z. Abreu, Sheila Cristina Lordelo Wludarski, Joaquim Teodoro de Araújo Neto, and Edison Mantovani Barbosa. "Primary breast lymphoma associated with invasive breast carcinoma: a case report." In XXVI Brazilian Mastology Congress. Mastology, 2024. https://doi.org/10.29289/259453942024v34s2039.

Full text
Abstract:
Introduction: This case report describes a 54-year-old patient who developed invasive breast carcinoma in her left breast without further specifications, of the luminal B molecular subtype, concurrently with a primary breast lymphoma (diffuse large B-cell lymphoma with the germinal center B-cell subtype), which was definitively diagnosed only after surgical intervention. Synchronous occurrence of breast cancer and non-Hodgkin lymphoma (NHL) is an uncommon situation, with only 38 cases reported in the literature. It is extremely rare for both tumors to present as a collision tumor within the sa
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Virus diseases – Chemotherapy' for particular source types:
Journal articles Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography